Table 4.
Analyte | N | Group | Hazard Ratio | R2 | P |
---|---|---|---|---|---|
| |||||
CRP *¶ | 93 | Placebo | 1.05 | 0.34 | 0.06 |
CRH* | 78 | Placebo | 1.00 | 0.28 | 0.995 |
Progesterone* | 96 | Placebo | 1.00 | 0.26 | 0.36 |
17-OHP * | 94 | Placebo | 1.04 | 0.20 | 0.44 |
| |||||
CRP** ¶ | 81 | 17-OHPC | 0.96 | 0.53 | 0.11 |
CRH* | 68 | 17-OHPC | 1.00 | 0.19 | 0.55 |
Progesterone** | 82 | 17-OHPC | 1.00 | 0.48 | 0.61 |
17-OHP* | 82 | 17-OHPC | 0.997 | 0.14 | 0.96 |
17-OHPC* | 83 | 17-OHPC | 1.14 | 0.49 | 0.001 |
adjusting for race/ethnicity, BMI and gestational age at blood draw
adjusting for 17-OHPC, race/ethnicity, BMI and gestational age at blood draw
medians of each CRP quartiles